Skip to content
PubMed This is a summary of 42 peer-reviewed journal articles Updated
Endocrinology

Navigating Autoimmune Polyendocrinopathy Type 2 (Schmidt Syndrome)

At a Glance

Autoimmune Polyendocrinopathy Type 2 (Schmidt Syndrome) is a rare autoimmune condition that affects multiple endocrine glands. Managing APS-2 requires coordinated care, usually led by an endocrinologist, to safely balance hormone replacements and prevent an adrenal crisis.

Getting diagnosed with a rare condition like Autoimmune Polyglandular Syndrome Type 2 (APS-2), also known as Schmidt Syndrome, can feel overwhelming [1]. This guide is designed to help you understand the framework of this condition, translating complex medical data into a strategic, empowering guide so you can regain control.

APS-2 is not a single disease that attacks everything at once; rather, it is a “syndrome”—a collection of conditions that tend to happen together because of a shared underlying immune system pattern [2]. Because it involves multiple endocrine glands, managing it requires awareness, a multidisciplinary care team, and a solid understanding of how your medications interact.

This resource guide is broken down into specific topics to help you navigate your journey with APS-2.

In This Guide:

Take your time reading through these sections. You can use the questions provided at the end of each page to prepare for your next endocrinology appointment. Knowledge is your best tool for safely managing APS-2.

Common questions in this guide

What is Autoimmune Polyendocrinopathy Type 2 (APS-2)?
APS-2, also known as Schmidt Syndrome, is a rare condition where the immune system mistakenly attacks multiple endocrine glands. It is considered a syndrome because it involves a collection of interconnected conditions rather than a single disease.
What kind of doctor treats Schmidt Syndrome?
Because APS-2 affects multiple endocrine glands, it requires a multidisciplinary medical team. Most patients rely on an endocrinologist to act as the primary specialist who coordinates treatment alongside their primary care doctor and other specialists.
Why is the 'Adrenals First' rule important for APS-2 treatment?
The 'Adrenals First' rule is a critical safety strategy for hormone replacement therapy in Schmidt Syndrome. It ensures that adrenal gland hormone deficiencies are treated before other hormone imbalances, which keeps your body stable and helps prevent a life-threatening adrenal crisis.
How do I prepare for an APS-2 medical emergency?
Staying safe requires mastering your sick-day rules and knowing exactly how and when to use your emergency injection kit. You should also organize your medical records and ensure you can clearly explain your condition to emergency medical responders.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How often should we review and update my overall care plan as my symptoms or age change?
  2. 2.Who should I consider the 'quarterback' of my medical team for managing this syndrome?
  3. 3.What is the best way for my different specialists (endocrinologist, primary care, etc.) to communicate with each other about my care?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (2)
  1. 1

    Adrenal crisis in a 14-year-old boy 12 years after hematopoietic stem cell transplantation.

    Penger T, Albrecht A, Marx M, et al.

    Endocrinology, diabetes & metabolism case reports 2018; (2018()).

    PMID: 29899990
  2. 2

    Adrenal crisis and autoimmune polyglandular syndromes.

    Freeland ZK, Lueking R, Tsai-Nguyen G, et al.

    Proceedings (Baylor University. Medical Center) 2017; (30(4)):427-428 doi:10.1080/08998280.2017.11930214.

    PMID: 28966452

This guide on Autoimmune Polyendocrinopathy Type 2 (APS-2) is for informational purposes only. Always consult your endocrinologist before adjusting medications or sick-day plans.

Get notified when new evidence is published on Autoimmune polyendocrinopathy type 2.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.